
Oral and rapid oral abstract session: renal cell cancer
In this video, Prof Dr Emmanuel Seront highlights one pivotal phase III trial and two biomarker-driven studies in renal cell carcinoma (RCC), focusing on treatment after immune checkpoint inhibitors and



